Scrip
Novo Nordisk's sales jump but still miss expectations
29 October 2009
Simon Varcoe
Please Login to read the full article.
29 October 2009
Simon Varcoe
simon.varcoe@informa.com
Novo Nordisk's sales and profits both surged during the third quarter on the back of strong performances by its diabetes care and biopharmaceuticals businesses.
The company's revenues and net profit both increased by 15% to DKK38.0 billion ($7.5 billion) and DKK 8.4 billion respectively....
Please Login to read the full article.
RELATED CONTENT
COMMENT
Other Informa Comment
